Gilead and Moderna lead on coronavirus treatments
Thursday, February 27, 2020 - 15:30
in Health & Medicine
Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via